{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:41:41Z","timestamp":1789623701580,"version":"build-2803163510"},"reference-count":51,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Institut Pasteur","award":["Equipe FRM 2012"],"award-info":[{"award-number":["Equipe FRM 2012"]}]},{"name":"Institut Pasteur","award":["FP7 N\u00b0 241500"],"award-info":[{"award-number":["FP7 N\u00b0 241500"]}]},{"name":"Institut Pasteur","award":["Emergence 2019"],"award-info":[{"award-number":["Emergence 2019"]}]},{"name":"INSERM U1224","award":["Equipe FRM 2012"],"award-info":[{"award-number":["Equipe FRM 2012"]}]},{"name":"INSERM U1224","award":["FP7 N\u00b0 241500"],"award-info":[{"award-number":["FP7 N\u00b0 241500"]}]},{"name":"INSERM U1224","award":["Emergence 2019"],"award-info":[{"award-number":["Emergence 2019"]}]},{"name":"Fondation Raoul Follereau","award":["Equipe FRM 2012"],"award-info":[{"award-number":["Equipe FRM 2012"]}]},{"name":"Fondation Raoul Follereau","award":["FP7 N\u00b0 241500"],"award-info":[{"award-number":["FP7 N\u00b0 241500"]}]},{"name":"Fondation Raoul Follereau","award":["Emergence 2019"],"award-info":[{"award-number":["Emergence 2019"]}]},{"name":"Fondation pour la Recherche M\u00e9dicale","award":["Equipe FRM 2012"],"award-info":[{"award-number":["Equipe FRM 2012"]}]},{"name":"Fondation pour la Recherche M\u00e9dicale","award":["FP7 N\u00b0 241500"],"award-info":[{"award-number":["FP7 N\u00b0 241500"]}]},{"name":"Fondation pour la Recherche M\u00e9dicale","award":["Emergence 2019"],"award-info":[{"award-number":["Emergence 2019"]}]},{"name":"European Community\u2019s Seventh Framework Programme","award":["Equipe FRM 2012"],"award-info":[{"award-number":["Equipe FRM 2012"]}]},{"name":"European Community\u2019s Seventh Framework Programme","award":["FP7 N\u00b0 241500"],"award-info":[{"award-number":["FP7 N\u00b0 241500"]}]},{"name":"European Community\u2019s Seventh Framework Programme","award":["Emergence 2019"],"award-info":[{"award-number":["Emergence 2019"]}]},{"DOI":"10.13039\/501100006431","name":"Canc\u00e9rop\u00f4le Ile de France","doi-asserted-by":"publisher","award":["Equipe FRM 2012"],"award-info":[{"award-number":["Equipe FRM 2012"]}],"id":[{"id":"10.13039\/501100006431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006431","name":"Canc\u00e9rop\u00f4le Ile de France","doi-asserted-by":"publisher","award":["FP7 N\u00b0 241500"],"award-info":[{"award-number":["FP7 N\u00b0 241500"]}],"id":[{"id":"10.13039\/501100006431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006431","name":"Canc\u00e9rop\u00f4le Ile de France","doi-asserted-by":"publisher","award":["Emergence 2019"],"award-info":[{"award-number":["Emergence 2019"]}],"id":[{"id":"10.13039\/501100006431","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation Fran\u00e7aise pour la Recherche contre le My\u00e9lome et les Gammapathies","award":["Equipe FRM 2012"],"award-info":[{"award-number":["Equipe FRM 2012"]}]},{"name":"Fondation Fran\u00e7aise pour la Recherche contre le My\u00e9lome et les Gammapathies","award":["FP7 N\u00b0 241500"],"award-info":[{"award-number":["FP7 N\u00b0 241500"]}]},{"name":"Fondation Fran\u00e7aise pour la Recherche contre le My\u00e9lome et les Gammapathies","award":["Emergence 2019"],"award-info":[{"award-number":["Emergence 2019"]}]},{"name":"Sanofi iAwards program 2020","award":["Equipe FRM 2012"],"award-info":[{"award-number":["Equipe FRM 2012"]}]},{"name":"Sanofi iAwards program 2020","award":["FP7 N\u00b0 241500"],"award-info":[{"award-number":["FP7 N\u00b0 241500"]}]},{"name":"Sanofi iAwards program 2020","award":["Emergence 2019"],"award-info":[{"award-number":["Emergence 2019"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>\u201cRecognizing a surprising fact is the first step towards discovery.\u201d This famous quote from Louis Pasteur is particularly appropriate to describe what led us to study mycolactone, a lipid toxin produced by the human pathogen Mycobacterium ulcerans. M. ulcerans is the causative agent of Buruli ulcer, a neglected tropical disease manifesting as chronic, necrotic skin lesions with a \u201csurprising\u201d lack of inflammation and pain. Decades after its first description, mycolactone has become much more than a mycobacterial toxin. This uniquely potent inhibitor of the mammalian translocon (Sec61) helped reveal the central importance of Sec61 activity for immune cell functions, the spread of viral particles and, unexpectedly, the viability of certain cancer cells. We report in this review the main discoveries that marked our research into mycolactone, and the medical perspectives they opened up. The story of mycolactone is not over and the applications of Sec61 inhibition may go well beyond immunomodulation, viral infections, and oncology.<\/jats:p>","DOI":"10.3390\/toxins15060369","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T02:27:30Z","timestamp":1685500050000},"page":"369","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["From Bacterial Toxin to Therapeutic Agent: The Unexpected Fate of Mycolactone"],"prefix":"10.3390","volume":"15","author":[{"given":"Daniela","family":"Ricci","sequence":"first","affiliation":[{"name":"Institut Pasteur, Universit\u00e9 Paris Cit\u00e9, Inserm U1224, Immunobiology and Therapy Unit, 75015 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Demangel","sequence":"additional","affiliation":[{"name":"Institut Pasteur, Universit\u00e9 Paris Cit\u00e9, Inserm U1224, Immunobiology and Therapy Unit, 75015 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nrmicro2077","article-title":"Buruli ulcer: Reductive evolution enhances pathogenicity of Mycobacterium ulcerans","volume":"7","author":"Demangel","year":"2009","journal-title":"Nat. Rev. MicroBiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.283.5403.854","article-title":"Mycolactone: A polyketide toxin from Mycobacterium ulcerans required for virulence","volume":"283","author":"George","year":"1999","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/imr.12956","article-title":"Immunity against Mycobacterium ulcerans: The subversive role of mycolactone","volume":"301","author":"Demangel","year":"2021","journal-title":"Immunol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-0716-1779-3_13","article-title":"Mycolactone Purification from M. ulcerans Cultures and HPLC-Based Approaches for Mycolactone Quantification in Biological Samples","volume":"Volume 2387","author":"Pluschke","year":"2022","journal-title":"Mycobacterium ulcerans"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.20070234","article-title":"Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone","volume":"204","author":"Coutanceau","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.4049\/jimmunol.0802294","article-title":"Mycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism","volume":"182","author":"Simmonds","year":"2009","journal-title":"J. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.4049\/jimmunol.0902854","article-title":"Mycolactone suppresses T cell responsiveness by altering both early signaling and posttranslational events","volume":"184","author":"Boulkroun","year":"2010","journal-title":"J. Immunol."},{"key":"ref_8","first-page":"289ra85","article-title":"Shaping mycolactone for therapeutic use against inflammatory disorders","volume":"7","author":"Baron","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.4049\/jimmunol.163.7.3928","article-title":"The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte\/T cell cytokine production and NF-kappa B function","volume":"163","author":"Pahlevan","year":"1999","journal-title":"J. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"12833","DOI":"10.1073\/pnas.1016496108","article-title":"Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression","volume":"108","author":"Carrette","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1084\/jem.20160662","article-title":"Mycolactone subverts immunity by selectively blocking the Sec61 translocon","volume":"213","author":"Baron","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1440-1711.2000.00935.x","article-title":"Interaction of dendritic cells with mycobacteria: Where the action starts","volume":"78","author":"Demangel","year":"2000","journal-title":"Immunol. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"E5910","DOI":"10.1073\/pnas.1705242114","article-title":"Sec61 blockade by mycolactone inhibits antigen cross-presentation independently of endosome-to-cytosol export","volume":"114","author":"Grotzke","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1021\/acschembio.7b00053","article-title":"The Macrolide Toxin Mycolactone Promotes Bim-Dependent Apoptosis in Buruli Ulcer through Inhibition of mTOR","volume":"12","author":"Bieri","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Hall, B.S., Hill, K., McKenna, M., Ogbechi, J., High, S., Willis, A.E., and Simmonds, R.E. (2014). The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004061"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1242\/jcs.182352","article-title":"Mechanistic insights into the inhibition of Sec61-dependent co- and post-translational translocation by mycolactone","volume":"129","author":"McKenna","year":"2016","journal-title":"J. Cell Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1242\/jcs.207829","article-title":"Multiple pathways facilitate the biogenesis of mammalian tail-anchored proteins","volume":"130","author":"Casson","year":"2017","journal-title":"J. Cell Sci."},{"key":"ref_18","first-page":"1","article-title":"An alternative pathway for membrane protein biogenesis at the endoplasmic reticulum","volume":"4","author":"Zong","year":"2021","journal-title":"Commun. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e01483","DOI":"10.7554\/eLife.01483","article-title":"An allosteric Sec61 inhibitor traps nascent transmembrane helices at the lateral gate","volume":"3","author":"Mackinnon","year":"2014","journal-title":"Elife"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature03821","article-title":"A substrate-specific inhibitor of protein translocation into the endoplasmic reticulum","volume":"436","author":"Garrison","year":"2005","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1074\/mcp.RA118.000824","article-title":"Proteomics Reveals Scope of Mycolactone-mediated Sec61 Blockade and Distinctive Stress Signature","volume":"17","author":"Morel","year":"2018","journal-title":"Mol. Cell. Proteom."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Itskanov, S., Wang, L., Junne, T., Sherriff, R., Xiao, L., Blanchard, N., Shi, W.Q., Forsyth, C., Hoepfner, D., and Spiess, M. (2022). A Common Mechanism of Sec61 Translocon Inhibition by Small Molecules. Nat. Chem. Biol., 1\u20139.","DOI":"10.1101\/2022.08.11.503542"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1039\/b803101k","article-title":"Mycolactones: Immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria","volume":"25","author":"Hong","year":"2008","journal-title":"Nat. Prod. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3762\/bjoc.13.159","article-title":"The chemistry and biology of mycolactones","volume":"13","author":"Gehringer","year":"2017","journal-title":"Beilstein J. Org. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Pluschke, G., and R\u00f6ltgen, K. (2019). Buruli Ulcer, Springer International Publishing.","DOI":"10.1007\/978-3-030-11114-4"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/cbic.200700411","article-title":"A Novel Mycolactone Toxin Obtained by Biosynthetic Engineering","volume":"8","author":"Hong","year":"2007","journal-title":"ChemBioChem"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1021\/ol0172828","article-title":"Total Synthesis of the Mycolactones","volume":"4","author":"Song","year":"2002","journal-title":"Org. Lett."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1002\/anie.200600012","article-title":"Stereoselective Synthesis of the Side Chains of Mycolactones A and B Featuring Stepwise Double Substitutions of 1,1-Dibromo-1-alkenes","volume":"45","author":"Yin","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"0415","DOI":"10.1055\/s-2007-967943","article-title":"Synthetic Studies on Mycolactones: Synthesis of the Mycolactone Core Structure through Ring-Closing Olefin Metathesis","volume":"2007","author":"Feyen","year":"2007","journal-title":"Synlett"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"14413","DOI":"10.1002\/chem.201102542","article-title":"A Diverted Total Synthesis of Mycolactone Analogues: An Insight into Buruli Ulcer Toxins","volume":"17","author":"Chany","year":"2011","journal-title":"Chem. Eur. J."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Scherr, N., Gersbach, P., Dangy, J.-P., Bomio, C., Li, J., Altmann, K.-H., and Pluschke, G. (2013). Structure-Activity Relationship Studies on the Macrolide Exotoxin Mycolactone of Mycobacterium ulcerans. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002143"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"13017","DOI":"10.1002\/chem.201101799","article-title":"A Ring-Closing Metathesis (RCM)-Based Approach to Mycolactones A\/B","volume":"17","author":"Gersbach","year":"2011","journal-title":"Chem. Eur. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/boc.201800030","article-title":"Sec61 blockade by mycolactone: A central mechanism in Buruli ulcer disease","volume":"110","author":"Demangel","year":"2018","journal-title":"Biol. Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41408-022-00695-5","article-title":"Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee","volume":"12","author":"Kumar","year":"2022","journal-title":"Blood Cancer J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e14740","DOI":"10.15252\/emmm.202114740","article-title":"The Sec61 translocon is a therapeutic vulnerability in multiple myeloma","volume":"14","author":"Domenger","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1110916","DOI":"10.3389\/fonc.2023.1110916","article-title":"Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma","volume":"13","author":"Domenger","year":"2023","journal-title":"Front. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41375-020-0734-z","article-title":"B-cell maturation antigen (BCMA) in multiple myeloma: Rationale for targeting and current therapeutic approaches","volume":"34","author":"Shah","year":"2020","journal-title":"Leukemia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1158\/1535-7163.MCT-15-0648","article-title":"Apratoxin A Shows Novel Pancreas-Targeting Activity through the Binding of Sec 61","volume":"15","author":"Huang","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/acsmedchemlett.7b00192","article-title":"Apratoxin S10, a Dual Inhibitor of Angiogenesis and Cancer Cell Growth To Treat Highly Vascularized Tumors","volume":"8","author":"Cai","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_41","first-page":"355","article-title":"HER3 signaling and targeted therapy in cancer","volume":"12","author":"Mishra","year":"2018","journal-title":"Oncol. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1038\/onc.2014.455","article-title":"Targeting HER3 by interfering with its Sec61-mediated cotranslational insertion into the endoplasmic reticulum","volume":"34","author":"Sandhu","year":"2015","journal-title":"Oncogene"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.immuni.2015.12.017","article-title":"Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection","volume":"44","author":"Heaton","year":"2016","journal-title":"Immunity"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.15252\/embj.201695597","article-title":"Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells","volume":"36","author":"Monel","year":"2017","journal-title":"EMBO J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.cell.2018.11.028","article-title":"Comparative Flavivirus-Host Protein Interaction Mapping Reveals Mechanisms of Dengue and Zika Virus Pathogenesis","volume":"175","author":"Shah","year":"2018","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1021\/np049629w","article-title":"Ipomoeassins A\u2212E, Cytotoxic Macrocyclic Glycoresins from the Leaves of Ipomoea s quamosa from the Suriname Rainforest","volume":"68","author":"Cao","year":"2005","journal-title":"J. Nat. Prod."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"8450","DOI":"10.1021\/jacs.8b13506","article-title":"Ipomoeassin F Binds Sec61\u03b1 to Inhibit Protein Translocation","volume":"141","author":"Zong","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"jcs257758","DOI":"10.1242\/jcs.257758","article-title":"Ipomoeassin-F inhibits the in vitro biogenesis of the SARS-CoV-2 spike protein and its host cell membrane receptor","volume":"134","author":"Roboti","year":"2021","journal-title":"J. Cell Sci."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Klein, W., Rutz, C., Eckhard, J., Provinciael, B., Specker, E., Neuenschwander, M., Kleinau, G., Scheerer, P., von Kries, J.-P., and Nazar\u00e9, M. (2018). Use of a sequential high throughput screening assay to identify novel inhibitors of the eukaryotic SRP-Sec61 targeting\/translocation pathway. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0208641"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Rehan, S., Tranter, D., Sharp, P.P., Lowe, E., Anderl, J.L., Muchamuel, T., Abrishami, V., Kuivanen, S., Wenzell, N., and Jennings, A. (2022). Signal peptide mimicry primes Sec61 for client-selective inhibition. Nat. Chem. Biol., 1\u20139.","DOI":"10.1101\/2022.07.03.498529"}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/15\/6\/369\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:45:38Z","timestamp":1760125538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/15\/6\/369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["toxins15060369"],"URL":"https:\/\/doi.org\/10.3390\/toxins15060369","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]}}}